| 000 | 01543 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515045521.0 | ||
| 264 | 0 | _c20070911 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1053-8569 | ||
| 024 | 7 |
_a10.1002/pds.1346 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonzález-Pérez, Antonio | |
| 245 | 0 | 0 |
_aGallbladder disease in the general population: association with cardiovascular morbidity and therapy. _h[electronic resource] |
| 260 |
_bPharmacoepidemiology and drug safety _cMay 2007 |
||
| 300 |
_a524-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlcohol Drinking _xepidemiology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholecystitis _xchemically induced |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDiuretics _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aObesity _xepidemiology |
| 650 | 0 | 4 |
_aPopulation Surveillance _xmethods |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSmoking _xepidemiology |
| 650 | 0 | 4 |
_aThiazides _xadverse effects |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aGarcía Rodríguez, Luis A | |
| 773 | 0 |
_tPharmacoepidemiology and drug safety _gvol. 16 _gno. 5 _gp. 524-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pds.1346 _zAvailable from publisher's website |
| 999 |
_c16675820 _d16675820 |
||